CVE-2024-24377

CVE-2024-24377 is a critical-severity vulnerability in Idocv Idocview with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-77.

Key facts

Description

An issue in idocv v.14.1.3_20231228 allows a remote attacker to execute arbitrary code and obtain sensitive information via a crafted script.

Frequently asked questions

What is CVE-2024-24377?
An issue in idocv v.14.1.3_20231228 allows a remote attacker to execute arbitrary code and obtain sensitive information via a crafted script.
How severe is CVE-2024-24377?
CVE-2024-24377 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2024-24377 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (62nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-24377?
CVE-2024-24377 affects Idocv Idocview. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-24377?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
Does CVE-2024-24377 have an EU (EUVD) identifier?
Yes. CVE-2024-24377 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-21799.
When was CVE-2024-24377 published?
CVE-2024-24377 was published on 2024-02-16 and last updated on 2026-06-17.

References

Affected products (1)

Other CWE-77 (Command Injection) vulnerabilities

Browse all CWE-77 (Command Injection) vulnerabilities →